Imperial College London
Portrait Picture

Professor Long R Jiao MD FRCS

Faculty of Medicine, Department of Surgery & Cancer

Professor of Surgery
 
 
 
//

Contact

 

+44 (0)20 3313 3937l.jiao

 
 
//

Location

 

BN1/15 Area BHammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{COVIDSurg:2020:10.1016/S0140-6736(20)31182-X,
author = {COVIDSurg, Collaborative and Jiao, LR},
doi = {10.1016/S0140-6736(20)31182-X},
journal = {The Lancet},
pages = {27--38},
title = {Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study},
url = {http://dx.doi.org/10.1016/S0140-6736(20)31182-X},
volume = {396},
year = {2020}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - BackgroundThe impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection.MethodsThis international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation.FindingsThis analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (74·0%) had emergency surgery and 280 (24·8%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (26·1%) patients. 30-day mortality was 23·8% (268 of 1128). Pulmonary complications occurred in 577 (51·2%) of 1128 patients; 30-day mortality in these patients was 38·0% (219 of 577), accounting for 81·7% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 1·75 [95% CI 1·28–2·40], p<0·0001), age 70 years or older versus younger than 70 years (2·30 [1·65–3·22], p<0·0001), American Society of Anesthesiologists grades 3–5 versus grades 1–2 (2·35 [1·57–3·53], p<0·0001), malignant versus benign or obstetric diagnosis (1·55 [1·01–2·39], p=0·046), emergency versus elective surgery (1·67 [1·06–2·63], p=0·026), and major versus minor surgery (1·52 [1&mi
AU  - COVIDSurg,Collaborative
AU  - Jiao,LR
DO  - 10.1016/S0140-6736(20)31182-X
EP  - 38
PY  - 2020///
SN  - 0140-6736
SP  - 27
TI  - Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
T2  - The Lancet
UR  - http://dx.doi.org/10.1016/S0140-6736(20)31182-X
UR  - https://www.sciencedirect.com/science/article/pii/S014067362031182X?via%3Dihub
UR  - http://hdl.handle.net/10044/1/80058
VL  - 396
ER  -
Download